Jianlong Lou

Title(s)Professor, Anesthesia
SchoolSchool of Medicine
Address1001 Potrero Ave
San Francisco CA 94110
vCardDownload vCard

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Multicolor fluorescence activated cell sorting to generate humanized monoclonal antibody binding seven subtypes of BoNT/F. PLoS One. 2022; 17(9):e0273512. Fan Y, Sun Z, Conrad F, Wen W, Zhao L, Lou J, Zhou Y, Farr-Jones S, Marks JD. PMID: 36048906; PMCID: PMC9436041.
      View in: PubMed   Mentions:
    2. A Four-Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotypes C and D. Toxins (Basel). 2021 09 10; 13(9). Garcia-Rodriguez C, Yan S, Geren IN, Knopp KA, Dong J, Sun Z, Lou J, Conrad F, Wen WH, Farr-Jones S, Smith TJ, Brown JL, Skerry JC, Smith LA, Marks JD. PMID: 34564645; PMCID: PMC8472335.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    3. A tumor-specific mechanism of Treg enrichment mediated by the integrin αvβ8. Sci Immunol. 2021 03 26; 6(57). Seed RI, Kobayashi K, Ito S, Takasaka N, Cormier A, Jespersen JM, Publicover J, Trilok S, Combes AJ, Chew NW, Chapman J, Krummel MF, Lou J, Marks J, Cheng Y, Baron JL, Nishimura SL. PMID: 33771888; PMCID: PMC8425767.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    4. Cryo-EM Reveals Integrin-Mediated TGF-β Activation without Release from Latent TGF-β. Cell. 2020 02 06; 180(3):490-501.e16. Campbell MG, Cormier A, Ito S, Seed RI, Bondesson AJ, Lou J, Marks JD, Baron JL, Cheng Y, Nishimura SL. PMID: 31955848; PMCID: PMC7238552.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    5. The Novel Clostridial Neurotoxin Produced by Strain IBCA10-7060 Is Immunologically Equivalent to BoNT/HA. Toxins (Basel). 2019 12 20; 12(1). Fan Y, Barash JR, Conrad F, Lou J, Tam C, Cheng LW, Arnon SS, Marks JD. PMID: 31877649; PMCID: PMC7020490.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCellsPHPublic Health
    6. Structural Studies avß8 Integrin by Single Particle Cryo-EM. Microscopy and Microanalysis. 2019 Aug 1; 25(S2):1312-1313. Campbell CM, Cormier CA, Ito IS, Wu WS, Lou LJ, Marks MJ, Baron BJ, Nishimura NS, Cheng CY. .
      View in: Publisher Site   Mentions:
    7. Botulinum Neurotoxins (BoNTs)-Antibody and Vaccine. Toxins (Basel). 2018 11 26; 10(12). Lou J, Marks JD. PMID: 30486254; PMCID: PMC6315911.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    8. Integrin αvβ8-expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells. JCI Insight. 2018 10 18; 3(20). Takasaka N, Seed RI, Cormier A, Bondesson AJ, Lou J, Elattma A, Ito S, Yanagisawa H, Hashimoto M, Ma R, Levine MD, Publicover J, Potts R, Jespersen JM, Campbell MG, Conrad F, Marks JD, Cheng Y, Baron JL, Nishimura SL. PMID: 30333313; PMCID: PMC6237456.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    9. Cryo-EM structure of the αvβ8 integrin reveals a mechanism for stabilizing integrin extension. Nat Struct Mol Biol. 2018 08; 25(8):698-704. Cormier A, Campbell MG, Ito S, Wu S, Lou J, Marks J, Baron JL, Nishimura SL, Cheng Y. PMID: 30061598; PMCID: PMC6214843.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    10. A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes. Toxins (Basel). 2018 03 01; 10(3). Garcia-Rodriguez C, Razai A, Geren IN, Lou J, Conrad F, Wen WH, Farr-Jones S, Smith TJ, Brown JL, Skerry JC, Smith LA, Marks JD. PMID: 29494481; PMCID: PMC5869393.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    11. A Single Tri-Epitopic Antibody Virtually Recapitulates the Potency of a Combination of Three Monoclonal Antibodies in Neutralization of Botulinum Neurotoxin Serotype A. Toxins (Basel). 2018 02 15; 10(2). Lou J, Wen W, Conrad F, Meng Q, Dong J, Sun Z, Garcia-Rodriguez C, Farr-Jones S, Cheng LW, Henderson TD, Brown JL, Smith TJ, Smith LA, Cormier A, Marks JD. PMID: 29462889; PMCID: PMC5848185.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    12. A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes. PLoS One. 2017; 12(3):e0174187. Fan Y, Garcia-Rodriguez C, Lou J, Wen W, Conrad F, Zhai W, Smith TJ, Smith LA, Marks JD. PMID: 28323873; PMCID: PMC5360321.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCellsPHPublic Health
    13. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H. J Infect Dis. 2016 May 15; 213(10):1606-14. Fan Y, Barash JR, Lou J, Conrad F, Marks JD, Arnon SS. PMID: 26936913; PMCID: PMC4837907.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    14. Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B. Toxins (Basel). 2015 Aug 26; 7(9):3405-23. Fan Y, Dong J, Lou J, Wen W, Conrad F, Geren IN, Garcia-Rodriguez C, Smith TJ, Smith LA, Ho M, Pires-Alves M, Wilson BA, Marks JD. PMID: 26343720; PMCID: PMC4591640.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    15. Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity. PLoS One. 2015; 10(8):e0135306. Fan Y, Geren IN, Dong J, Lou J, Wen W, Conrad F, Smith TJ, Smith LA, Ho M, Pires-Alves M, Wilson BA, Marks JD. PMID: 26275214; PMCID: PMC4537209.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    16. TGF-β-Dependent Dendritic Cell Chemokinesis in Murine Models of Airway Disease. J Immunol. 2015 Aug 01; 195(3):1182-90. Hashimoto M, Yanagisawa H, Minagawa S, Sen D, Ma R, Murray LA, Tsui P, Lou J, Marks JD, Baron JL, Krummel MF, Nishimura SL. PMID: 26109638; PMCID: PMC4506848.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    17. Transforming Growth Factor-β and Interleukin-1β Signaling Pathways Converge on the Chemokine CCL20 Promoter. J Biol Chem. 2015 Jun 05; 290(23):14717-28. Brand OJ, Somanath S, Moermans C, Yanagisawa H, Hashimoto M, Cambier S, Markovics J, Bondesson AJ, Hill A, Jablons D, Wolters P, Lou J, Marks JD, Baron JL, Nishimura SL. PMID: 25918170; PMCID: PMC4505537.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    18. 131. Human antibody engineering for prevention and treatment of botulinum neurotoxin (BoNT) intoxication. Toxicon. 2015 Jan 1; 93:s40-s41. Lou LJ, Garcia-Rodriguez GC, Fan FY, Dong DJ, Wen WW, Conrad CF, Manzanarez MG, Sanchez SM, Marks MJ. .
      View in: Publisher Site   Mentions:
    19. Development of an ELISA microarray assay for the sensitive and simultaneous detection of ten biodefense toxins. Analyst. 2014 Oct 21; 139(20):5093-102. Jenko KL, Zhang Y, Kostenko Y, Fan Y, Garcia-Rodriguez C, Lou J, Marks JD, Varnum SM. PMID: 25112421; PMCID: PMC6540756.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    20. Selective targeting of TGF-β activation to treat fibroinflammatory airway disease. Sci Transl Med. 2014 Jun 18; 6(241):241ra79. Minagawa S, Lou J, Seed RI, Cormier A, Wu S, Cheng Y, Murray L, Tsui P, Connor J, Herbst R, Govaerts C, Barker T, Cambier S, Yanagisawa H, Goodsell A, Hashimoto M, Brand OJ, Cheng R, Ma R, McKnelly KJ, Wen W, Hill A, Jablons D, Wolters P, Kitamura H, Araya J, Barczak AJ, Erle DJ, Reichardt LF, Marks JD, Baron JL, Nishimura SL. PMID: 24944194; PMCID: PMC4341974.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimals
    21. Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A. FEBS Lett. 2014 Apr 02; 588(7):1087-93. Strotmeier J, Mahrhold S, Krez N, Janzen C, Lou J, Marks JD, Binz T, Rummel A. PMID: 24583011; PMCID: PMC4067265.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    22. RNA aptasensor for rapid detection of natively folded type A botulinum neurotoxin. Talanta. 2013 Dec 15; 117:273-80. Janardhanan P, Mello CM, Singh BR, Lou J, Marks JD, Cai S. PMID: 24209341; PMCID: PMC3909959.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    23. Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E. Biochem J. 2013 Jul 01; 453(1):37-47. Mahrhold S, Strotmeier J, Garcia-Rodriguez C, Lou J, Marks JD, Rummel A, Binz T. PMID: 23621114.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    24. Development of an ELISA microarray platform for the sensitive and quantitative detection of botulinum neurotoxins. Toxicon. 2013 Jun 1; 68:101. Zhang ZY, Lou LJ, Marks MJ, Jenko JK, Varnum VS. .
      View in: Publisher Site   Mentions:
    25. Comparison of neutralizing abilities of human monoclonal antibodies binding different epitopes on botulinum neurotoxin A. Toxicon. 2013 Jun 1; 68:98-99. Sun SZ, Lou LJ, Cheng CL, Smith ST, Dong DJ, Wen WW, Conrad CF, Garcia GC, Fan FY, Henderson HT, Brown BJ, Skerry SJ, Smith SL, Harrison HT, D'Andrea DA, Tomic TM, Marks MJ. .
      View in: Publisher Site   Mentions:
    26. Generation, expression and purification of monoclonal-antibody-specific engineered domains to support development of oligoclonal recombinant antitoxins against BoNT/B and BoNT/E. Toxicon. 2013 Jun 1; 68:90. Meng MQ, Garcia GC, Silberg SM, Manzanarez MG, Lou LJ, Fan FY, Conrad CF, Li LM, Freeberg FJ, Bettencourt BJ, Breece BT, Pan PX, Ma MJ, To TB, Obi OC, Tomic TM, Marks MJ. .
      View in: Publisher Site   Mentions:
    27. Quantification of botulinum neurotoxin in intoxicated neurons. Toxicon. 2013 Jun 1; 68:88-89. Bagramyan BK, Trinh TD, Lou LJ, Sun SZ, Marks MJ, Kalkum KM. .
      View in: Publisher Site   Mentions:
    28. Monoclonal antibodies against botulinum neurotoxin serotype F. Toxicon. 2013 Jun 1; 68:85-86. Fan FY, Lou LJ, Garcia GC, Zhai ZW, Dong DJ, Wen WW, Conrad CF, Brown BJ, Skerry SJ, Smith ST, Smith SL, Marks MJ. .
      View in: Publisher Site   Mentions:
    29. Recombinant monoclonal-antibody-based antitoxins for treatment of types A, B, and E botulism. Toxicon. 2013 Jun 1; 68:99-100. Tomic TM, Garcia GC, Lou LJ, Geren GI, Meng MQ, Conrad CF, Wen WW, Smith ST, Brown BJ, Smith SL, Wajid WA, Dadson DA, Horwitz HA, Freeberg FJ, Marks MJ. .
      View in: Publisher Site   Mentions:
    30. Human monoclonal antibodies binding botulinum neurotoxin types C, D, and mosaic neurotoxins C-D and D-C. Toxicon. 2013 Jun 1; 68:86-87. Garcia GC, Yan YS, Geren GI, Lou LJ, Wen WW, Conrad CF, Smith ST, Brown BJ, Skerry SJ, Smith SL, Marks MJ. .
      View in: Publisher Site   Mentions:
    31. Simultaneous and sensitive detection of six serotypes of botulinum neurotoxin using enzyme-linked immunosorbent assay-based protein antibody microarrays. Anal Biochem. 2012 Nov 15; 430(2):185-92. Zhang Y, Lou J, Jenko KL, Marks JD, Varnum SM. PMID: 22935296; PMCID: PMC3589981.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    32. Impact of intrinsic affinity on functional binding and biological activity of EGFR antibodies. Mol Cancer Ther. 2012 Jul; 11(7):1467-76. Zhou Y, Goenaga AL, Harms BD, Zou H, Lou J, Conrad F, Adams GP, Schoeberl B, Nielsen UB, Marks JD. PMID: 22564724; PMCID: PMC4209485.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    33. Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies. BMC Biochem. 2011 Nov 15; 12:58. Kalb SR, Santana WI, Geren IN, Garcia-Rodriguez C, Lou J, Smith TJ, Marks JD, Smith LA, Pirkle JL, Barr JR. PMID: 22085466; PMCID: PMC3250939.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    34. Affinity maturation to improve human monoclonal antibody neutralization potency and breadth against hepatitis C virus. J Biol Chem. 2011 Dec 23; 286(51):44218-44233. Wang Y, Keck ZY, Saha A, Xia J, Conrad F, Lou J, Eckart M, Marks JD, Foung SKH. PMID: 22002064; PMCID: PMC3243554.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    35. Response re: ‘Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin' by Garcia-Rodriguez et al., PEDS, 2011;24:321–331. Protein Engineering Design and Selection. 2011 Sep 1; 24(9):633-634. Garcia-Rodriguez GC, Geren GI, Lou LJ, Conrad CF, Forsyth FC, Wen WW, Chakraborti CS, Zao ZH, Manzanarez MG, Smith ST, Brown BJ, Tepp TW, Liu LN, Wijesuriya WS, Tomic TM, Johnson JE, Smith SL, Marks MJ. .
      View in: Publisher Site   Mentions:
    36. Antibodies that bind integrin Alpha-V Beta-8. 2011. Stephen Nishimura, Jianlong Lou, Jody Lynn Baron, James D Marks.
    37. Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin αvβ8-mediated activation of TGF-β. J Clin Invest. 2011 Jul; 121(7):2863-75. Kitamura H, Cambier S, Somanath S, Barker T, Minagawa S, Markovics J, Goodsell A, Publicover J, Reichardt L, Jablons D, Wolters P, Hill A, Marks JD, Lou J, Pittet JF, Gauldie J, Baron JL, Nishimura SL. PMID: 21646718; PMCID: PMC3223836.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansAnimalsCells
    38. Response re: 'Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin' by Garcia-Rodriguez et al., PEDS, 2011;24:321-331. Protein Eng Des Sel. 2011 Apr 18. Garcia-Rodriguez C, Geren IN, Lou J, Conrad F, Forsyth C, Wen W, Chakraborti S, Zao H, Manzanarez G, Smith TJ, Brown J, Tepp WH, Liu N, Wijesuriya S, Tomic MT, Johnson EA, Smith LA, Marks JD. PMID: 21502303.
      View in: PubMed   Mentions:
    39. Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors. Cancer Res. 2011 Mar 15; 71(6):2250-9. Rudnick SI, Lou J, Shaller CC, Tang Y, Klein-Szanto AJ, Weiner LM, Marks JD, Adams GP. PMID: 21406401; PMCID: PMC3077882.
      View in: PubMed   Mentions: 124     Fields:    Translation:HumansAnimalsCells
    40. INTEGRIN αVβ8 NEUTRALIZING ANTIBODY. 2010. Stephen Nishimura, Jianlong Lou, Jody Lynn Baron, James D Marks.
    41. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Protein Eng Des Sel. 2011 Mar; 24(3):321-31. Garcia-Rodriguez C, Geren IN, Lou J, Conrad F, Forsyth C, Wen W, Chakraborti S, Zao H, Manzanarez G, Smith TJ, Brown J, Tepp WH, Liu N, Wijesuriya S, Tomic MT, Johnson EA, Smith LA, Marks JD. PMID: 21149386; PMCID: PMC3038462.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    42. Anti-Botulinum Neurotoxin Antibodies. 2010. James D. Marks, Jianbo Dong, Jianlong Lou. . View Publication.
    43. Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS. PLoS One. 2010 Aug 17; 5(8):e12237. Kalb SR, Garcia-Rodriguez C, Lou J, Baudys J, Smith TJ, Marks JD, Smith LA, Pirkle JL, Barr JR. PMID: 20808925; PMCID: PMC2923190.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    44. THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS. 2010. James D Marks, Isin Geren, Maria Consuelo Garcia, Jianlong Lou, Ali Razai. View Publication.
    46. Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating. Protein Eng Des Sel. 2010 Apr; 23(4):311-9. Lou J, Geren I, Garcia-Rodriguez C, Forsyth CM, Wen W, Knopp K, Brown J, Smith T, Smith LA, Marks JD. PMID: 20156888; PMCID: PMC2841544.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    47. Tumor detection by imaging proteolytic activity. Cancer Res. 2010 Feb 15; 70(4):1505-12. Darragh MR, Schneider EL, Lou J, Phojanakong PJ, Farady CJ, Marks JD, Hann BC, Craik CS. PMID: 20145119; PMCID: PMC2823079.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    48. A single-domain llama antibody potently inhibits the enzymatic activity of botulinum neurotoxin by binding to the non-catalytic alpha-exosite binding region. J Mol Biol. 2010 Apr 09; 397(4):1106-18. Dong J, Thompson AA, Fan Y, Lou J, Conrad F, Ho M, Pires-Alves M, Wilson BA, Stevens RC, Marks JD. PMID: 20138889; PMCID: PMC2903050.
      View in: PubMed   Mentions: 40     Fields:    Translation:AnimalsCells
    49. Antibody Engineering. Roland Kontermann and Stefan Dübel (Eds.). Affinity Maturation by Chain Shuffling and Site Directed Mutagenesis. 2010; 377-396. Jianlong Lou and James D Marks. .
    50. Affinity Maturation by Chain Shuffling and Site Directed Mutagenesis. Antibody Engineering. 2010 Jan 1; 377-396. Lou LJ, Marks MJ. .
      View in: Publisher Site   Mentions:
    51. Antibody protection against botulinum neurotoxin intoxication in mice. Infect Immun. 2009 Oct; 77(10):4305-13. Cheng LW, Stanker LH, Henderson TD, Lou J, Marks JD. PMID: 19651864; PMCID: PMC2747958.
      View in: PubMed   Mentions: 56     Fields:    Translation:AnimalsCells
    52. Rapid multiplexed flow cytometric assay for botulinum neurotoxin detection using an automated fluidic microbead-trapping flow cell for enhanced sensitivity. Anal Chem. 2009 Jul 15; 81(14):5783-93. Ozanich RM, Bruckner-Lea CJ, Warner MG, Miller K, Antolick KC, Marks JD, Lou J, Grate JW. PMID: 19530657.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    53. Quantum dot immunoassays in renewable surface column and 96-well plate formats for the fluorescence detection of botulinum neurotoxin using high-affinity antibodies. Biosens Bioelectron. 2009 Sep 15; 25(1):179-84. Warner MG, Grate JW, Tyler A, Ozanich RM, Miller KD, Lou J, Marks JD, Bruckner-Lea CJ. PMID: 19643593; PMCID: PMC2728038.
      View in: PubMed   Mentions: 11     Fields:    
    54. Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies. PLoS One. 2009; 4(4):e5355. Kalb SR, Lou J, Garcia-Rodriguez C, Geren IN, Smith TJ, Moura H, Marks JD, Smith LA, Pirkle JL, Barr JR. PMID: 19399171; PMCID: PMC2670495.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    55. Renewable surface fluorescence sandwich immunoassay biosensor for rapid sensitive botulinum toxin detection in an automated fluidic format. Analyst. 2009 May; 134(5):987-96. Grate JW, Warner MG, Ozanich RM, Miller KD, Colburn HA, Dockendorff B, Antolick KC, Anheier NC, Lind MA, Lou J, Marks JD, Bruckner-Lea CJ. PMID: 19381395.
      View in: PubMed   Mentions: 7     Fields:    Translation:Cells
    56. Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins. 2009. Marks James D; Geren Isin N; Garcia Maria Consuelo; Lou Jianlong; Razai Ali. View Publication.
    57. The use of Endopep-MS to detect multiple subtypes of botulinum neurotoxins A, B, E, and F. International Journal of Mass Spectrometry. 2008 Dec 1; 278(2-3):101-108. Kalb KS, Smith ST, Moura MH, Hill HK, Lou LJ, Geren GI, Garcia-Rodriguez GC, Marks MJ, Smith SL, Pirkle PJ, Barr BJ. .
      View in: Publisher Site   Mentions:
    58. Development of human single-chain antibodies against SARS-associated coronavirus. Intervirology. 2008; 51(3):173-81. Leung KM, Feng DX, Lou J, Zhou Y, Fung KP, Waye MM, Tsui SK, Chan PK, Marks JD, Pang SF, Kan YW. PMID: 18724064; PMCID: PMC7179547.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    59. Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins. 2008. Marks James D; Amersdorfer Peter; Geren Isin; Lou Jianlong; Razai Ali; Garcia Maria Consuelos. View Publication.
    60. Toxicon. Recombinant antibody potently neutralizes types A, B, and E botulinum neurotoxins by a clearance-driven mechanism. 2008; 51(Summlement):50. Marks James, Garcia Consuelo, Isin N. Geren, Lou Jianlong, Charles M. Forsyth, Fraser Conrad, Wen Weihua, Theresa J. Smith, Brown Jennifer, Al-Saleem Fetweh, Ancharski Denise, Lance L. Simpson, William H. Tepp, Eric A. Johnson and Leonard A. Smith. View Publication.
    61. Molecular architecture of botulinum neurotoxin E revealed by single particle electron microscopy. J Biol Chem. 2008 Feb 15; 283(7):3997-4003. Fischer A, Garcia-Rodriguez C, Geren I, Lou J, Marks JD, Nakagawa T, Montal M. PMID: 18032388.
      View in: PubMed   Mentions: 21     Fields:    Translation:Cells
    62. Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen. J Immunol. 2007 Sep 01; 179(5):2815-23. Tang Y, Lou J, Alpaugh RK, Robinson MK, Marks JD, Weiner LM. PMID: 17709495.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    63. THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS. 2007. James D Marks, Peter Amersdorfer, Isin Geren, Jianlong Lou, Ali Razai, Consuelos Maria Garcia.
    64. Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin. Nat Biotechnol. 2007 Jan; 25(1):107-16. Garcia-Rodriguez C, Levy R, Arndt JW, Forsyth CM, Razai A, Lou J, Geren I, Stevens RC, Marks JD. PMID: 17173035.
      View in: PubMed   Mentions: 85     Fields:    Translation:Cells
    65. Using phage display to select antibodies recognizing post-translational modifications independently of sequence context. Mol Cell Proteomics. 2006 Dec; 5(12):2350-63. Kehoe JW, Velappan N, Walbolt M, Rasmussen J, King D, Lou J, Knopp K, Pavlik P, Marks JD, Bertozzi CR, Bradbury AR. PMID: 16971384.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    66. High affinity promotes more effective ADCC by anti-HER2/ neu monoclonal antibodies. Journal of Clinical Oncology. 2006 Jun 20; 24(18_suppl):2538-2538. Tang TY, Alpaugh AK, Lou LJ, Litwin LS, Shaller SC, Adams AG, Marks MJ, Weiner WL. .
      View in: Publisher Site   Mentions:
    67. Enzyme-amplified protein microarray and a fluidic renewable surface fluorescence immunoassay for botulinum neurotoxin detection using high-affinity recombinant antibodies. Anal Chim Acta. 2006 Jun 16; 570(2):137-43. Varnum SM, Warner MG, Dockendorff B, Anheier NC, Lou J, Marks JD, Smith LA, Feldhaus MJ, Grate JW, Bruckner-Lea CJ. PMID: 17723391.
      View in: PubMed   Mentions: 12     Fields:    
    68. Isolation of scFvs to in vitro produced extracellular domains of EGFR family members. Cancer Biother Radiopharm. 2005 Dec; 20(6):603-13. Horak E, Heitner T, Robinson MK, Simmons HH, Garrison J, Russeva M, Furmanova P, Lou J, Zhou Y, Yuan QA, Weiner LM, Adams GP, Marks JD. PMID: 16398612.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    69. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect Immun. 2005 Sep; 73(9):5450-7. Smith TJ, Lou J, Geren IN, Forsyth CM, Tsai R, Laporte SL, Tepp WH, Bradshaw M, Johnson EA, Smith LA, Marks JD. PMID: 16113261; PMCID: PMC1231122.
      View in: PubMed   Mentions: 121     Fields:    Translation:AnimalsCells
    70. Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A. J Mol Biol. 2005 Aug 05; 351(1):158-69. Razai A, Garcia-Rodriguez C, Lou J, Geren IN, Forsyth CM, Robles Y, Tsai R, Smith TJ, Smith LA, Siegel RW, Feldhaus M, Marks JD. PMID: 16002090.
      View in: PubMed   Mentions: 58     Fields:    Translation:Cells
    71. Yeast mating for combinatorial Fab library generation and surface display. FEBS Lett. 2004 Apr 23; 564(1-2):24-34. Weaver-Feldhaus JM, Lou J, Coleman JR, Siegel RW, Marks JD, Feldhaus MJ. PMID: 15094038.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    72. Antibodies in proteomics II: screening, high-throughput characterization and downstream applications. Trends Biotechnol. 2003 Jul; 21(7):312-7. Bradbury A, Velappan N, Verzillo V, Ovecka M, Chasteen L, Sblattero D, Marzari R, Lou J, Siegel R, Pavlik P. PMID: 12837616.
      View in: PubMed   Mentions: 8     Fields:    Translation:Cells
    73. Antibodies in proteomics I: generating antibodies. Trends Biotechnol. 2003 Jun; 21(6):275-81. Bradbury A, Velappan N, Verzillo V, Ovecka M, Chasteen L, Sblattero D, Marzari R, Lou J, Siegel R, Pavlik P. PMID: 12788548.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    74. Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries. J Immunol Methods. 2001 Jul 01; 253(1-2):233-42. Lou J, Marzari R, Verzillo V, Ferrero F, Pak D, Sheng M, Yang C, Sblattero D, Bradbury A. PMID: 11384684.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    75. In vivo recombination as a tool to generate molecular diversity in phage antibody libraries. J Biotechnol. 2001 Jun; 74(4):303-15. Sblattero D, Lou J, Marzari R, Bradbury A. PMID: 11526909.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    76. Applied Biotoxin and Toxicology , Chen Ning Qing, Meng Zhao He( Eds),. Sterigmatocystin. 2001; 311-329. Lou Jian Long.
    77. Modern Microbiology and Toxicology Jiao Bing Hua, Xie Zheng Yang( Eds). Sterigmatocystin. 2000; 374-383. Lou Jian Long.
    78. Voltammetric behavior of mammalian tumor cells and bioanalytical applications in cell metabolism. Bioelectrochem Bioenerg. 1999 Feb; 48(1):217-22. Feng J, Ci YX, Lou JL, Zhang XQ. PMID: 10228590.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    79. Electromagnetic Biology and Medicine. Electrochemical Voltammetric Features in Living Tissues of MICE. 1999; 18(3):317-323. Jun Feng, Ti Yu Gao, Jian Long Lou, Yun Xiang Ci and Zhen Quan Guo. View Publication.
    80. Production and characterization of a monoclonal antibody against sterigmatocystin. Biomed Environ Sci. 1996 Mar; 9(1):17-25. Lou JL, Guo ZQ, Meng ZH. PMID: 8721623.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    81. Tumor in China. The Correlation of Sterigmatocystin and Human Cancer. 1996; 5(8):26-27. Meng Zhao He, Lou Jian Long, Guo Zhen Quan, Tian He Jing, and Liu Zhao Qian.
    82. [Production and characterization of sterigmatocystin]. Wei Sheng Wu Xue Bao. 1995 Oct; 35(5):358-63. Lou J, Wang Y, Wang D, Meng Z. PMID: 8701584.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    83. [Determination of sterigmatocystin in cancerous tissues, blood and urine in patients with liver and stomach cancer]. Zhonghua Yu Fang Yi Xue Za Zhi. 1995 Sep; 29(5):276-8. Tian H, Lou J, Du C. PMID: 8556937.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    84. [Preparation and identification of monoclonal antibody against sterigmatocystin]. Zhonghua Yu Fang Yi Xue Za Zhi. 1995 Mar; 29(2):92-5. Lou J, Guo Z, Meng Z. PMID: 7796690.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCellsPHPublic Health
    85. Production and characterization of sterigmatocystin. Biomed Environ Sci. 1994 Dec; 7(4):293-301. Lou JL, Meng ZH, Wang DS. PMID: 7702759.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    86. Journal of Hygiene Research. Screening of sterigmatocystin-producing aspergillus strains. 1993; 22(5):299-302. Lou Jianlong, Meng Zhaohe.
    87. Progress in Sterigmatocystin Research. 1992. Lou Jian Long, Meng Zhao He.
    88. Medical Science Abroad. Progress in Sterigmatocystin Research. 1992; 19(4):218-221. Lou Jian Long, Meng Zhao He.
    89. Chinese Journal of Public Health. Production and Application of Antibody against Sterigmatocystin. 1991; 10(6):367-370. Lou Jian Long, Zou Kang Nan.
    Jianlong's Networks
    Concepts (269)
    Derived automatically from this person's publications.
    Co-Authors (15)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department